Acta Scientific Cancer Biology (ASCB) aims to promote communication among clinical researchers worldwide. The journal aims to publish original work in all the areas of cancer biology and clinical oncology. The journal focus on the novel concepts, new methodologies, advanced regimens, novel therapeutic agents and alternative approaches for early detection and intervention of cancer. International Journal of Cancer Biology and Clinical Oncology journal works with a determination to show an open window of the progress in oncological sciences.
Internationally profound journal that Publishes articles on various disciplines of Cancer.
Thorough Double blinded peer review.
Prompt Acknowledgement after acceptance of article for peer review.
Rapid Publication after the article is peer reviewed through eminent reviewers.
Acceptance and Publication of papers with excellence, novelty and originality.
Issue of Publication Certificate to author.
We Provide High visibility of your Published work.
As cancer, has become a major, serious and a complex problem, it is very essential to put a huge effort to understand and control it, that is possible with the help of original and innovative research findings that helps to disseminate knowledge regarding the etiology of cancer and improvements can be made in its treatment that facilitates the survival of patients. Acta Scientific Cancer Biology (ASCB) is a platform to bring into light the major advances in cancer research and oncology.
The research areas covered by the journal include, but are not restricted to the following fields:
Molecular and cellular mechanisms of cancer, Mechanisms for the sensitivity and the resistance to cancer therapies and development of better cancer therapies, Cancer genetics, Cancer cytology, Cancer pathology, Gynecologic cancer, Ovarian cancer, Clinical aspects of cancer, Liver cancer, Lung cancer, Cancer endocrinology, Genitourinary cancer, Colorectal cancer, Bone cancer, Prostate cancer, Benign tumours, Cancer chemotherapy, Pediatric oncology, Cancer prevention, Recent developments in tumor therapy, Radiation oncology, Apoptosis, Oncogenes, Angiogenesis, Metastasis, Cancer image and interventional diagnosis and therapy, Tumor markers, Chemotherapy, Radiotherapy and biotherapy, Veterinary and Comparative oncology, Clinical trials in oncology, Cancer nanotechnology, Carcinoma, Sarcoma, Myeloma, Leukemia, Lymphoma, Osteosarcoma or Osteogenic sarcoma, Chondrosarcoma, Leiomyosarcoma, Rhabdomyosarcoma, Mesothelial sarcoma or mesothelioma, Fibrosarcoma, Angiosarcoma or Haemangioendothelioma, Liposarcoma, Glioma or Astrocytoma, Myxosarcoma, Mesenchymous or Mixed mesodermal tumor. All the topics relevant to cancer are accepted by International Journal of Cancer Biology and Clinical Oncology that aims to provide information on original cancer research.
European Clinical, Molecular and Pathological (ECMP) Criteria for Prefibrotic JAK2V617F Mutated Essential Thrombocythemia (ET) and Polycythemia Vera (PV), MPL515 Normocellular ET and CALR Mutated ET Associated with Primary Megakaryocytic Granulocytic Myeloproliferation (PMGM): From Dameshek to Michiels 1950-2018
Study of Salivary and Epithelial Cell Glycoproteins and Sialic Acid as Biomarkers in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma- A Proposed Hypothesis of Potential Pathogenesis during Malignant Transformation
Increased Incidence of People who are Exposed to Multiple Cancer-Contributing Parameters Appear to Develop Cancer in Relatively Short Period of Time. Thus, Both Diagnosis and Safe, Effective Treatment should Take Care of Specific, Multiple Contributing Factors to Each Individual Patient. Individualized, Safe, Effective Treatment of Cancer should Include Optimal dose of Vitamin D3 Because of its 10 Unique, Beneficial Effects and Thymus Gland Stimulation which Release Thymosin A1 with Significant Anti-Cancer Effects, etc